| Financial Year |
March 31 2023 |
| Monetary Funds |
524,367,798.25 |
| Held-for-trading Financial Assets |
4,308.01 |
| Notes Receivable |
25,751,818.39 |
| Accounts Receivable |
601,404,624.62 |
| Advances to Suppliers |
46,865,369.19 |
| Other Receivables |
36,852,738.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
448,796,190.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
34,217,315.94 |
| Total Current Assets |
1,824,929,265.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
62,447,615.92 |
| Investment Properties |
-- |
| Fixed Assetes |
958,658,949.97 |
| Under-construction Projects |
192,238,737.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
245,445,545.08 |
| R&D expenses |
-- |
| Goodwill |
371,652,107.24 |
| Long-Term Deferred and Prepaid Expenses |
410,514.44 |
| Deferred Income Tax Assets |
51,277,930.37 |
| Other Non-Current Assets |
62,214,055.07 |
| Sub-Total of Non-Current Assets |
2,326,769,958.03 |
| Total Assets |
4,151,699,223.80 |
| Short-Term Loans |
519,019,950.62 |
| Trading Financial liabilities |
363,692.01 |
| Notes Payable |
223,713,922.67 |
| Accounts Payable |
242,322,473.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,365,809.31 |
| Taxes Payable |
26,594,520.84 |
| Interest Payable |
-- |
| Dividend Payable |
2,450,000.00 |
| Other payables |
54,701,689.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
111,772,735.73 |
| Other Current Liabilities |
11,529,282.83 |
| Sub-Total of Current Liabilities |
1,209,414,484.94 |
| Long-term Loans |
263,600,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,530,944.84 |
| Deferred Income Tax Liabilities |
42,296,279.27 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
355,341,965.30 |
| Total Liabilities |
1,564,756,450.24 |
| Paid-In Capital(Or Share Stock) |
963,309,471.00 |
| Capital Surplus |
681,724,638.46 |
| Surplus Reserve |
50,821,542.20 |
| LESS:Treasury Stock |
34,982,791.65 |
| Undistributed Profits |
778,723,971.46 |
| Minority Stockholder's Interest |
140,694,554.35 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,446,248,219.21 |
| Owner's Equity（Stockholder's Equity） |
2,586,942,773.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,151,699,223.80 |
